Expert Insights: Advances in Monitoring and Interventions for Emerging Infectious Diseases
Last updated: 11/2022
Overview
Emerging infectious disease is a rising area of focus for global health. In the last 50 years, over 40 new diseases have emerged globally. Scientists use technologies such as advanced flow cytometry, ligand-based antibody binding assays, and live cell imaging and analysis to gain meaningful insights that allow for the rapid development of therapeutics.
This Expert Insights publication provides an overview of recent advances in research for emerging infectious diseases. The studies include descriptions regarding advances in scaffold platforms for identifying novel mimetic ligands for blocking viral binding and the development of novel methods for detection of antibodies from patient samples.
- Document type: eBook
- Page count: 28
Key Takeaways:
- Engineering defensin α-helix to produce high-affinity SARS-CoV-2 Spike protein binding ligands
- A functional assay for serum detection of antibodies against SARS-CoV-2 nucleoprotein
- Evaluating viral infections across the entire host-pathogen life cycle
- Advanced flow cytometry applications in infectious disease and immuno-oncology
This Resource is Designed for:
- COVID- 19 researchers, vaccine developer in Biopharma/Pharma and Biotech (80%) & Academic institutions (20%), government and environmental agencies and labs primarily working on testing, R&D, vaccine research, virology and detection of SARS-CoV-2 in the air and wastewater.
Applications Supported:
- Cell Analysis